speb/financial-data huggingface dataset:
ACU.AX balance_sheet (annual, 2025-06-30) — Total Assets: 38284000.00
ACU.AX balance_sheet (quarterly, 2025-06-30) — Total Assets: 38284000.00
ACU.AX balance_sheet (annual, 2025-06-30) — Total Capitalization: 26041000.00
ACU.AX balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 26041000.00
ACU.AX balance_sheet (annual, 2025-06-30) — Total Debt: 2051000.00
ACU.AX balance_sheet (quarterly, 2025-06-30) — Total Debt: 2051000.00
ACU.AX balance_sheet (annual, 2025-06-30) — Total Equity Gross Minority Interest: 26041000.00
ACU.AX balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 26041000.00
ACU.AX balance_sheet (annual, 2025-06-30) — Total Liabilities Net Minority Interest: 12243000.00
ACU.AX balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 12243000.00
ACU.AX balance_sheet (annual, 2025-06-30) — Total Non Current Assets: 26299000.00
ACU.AX balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 26299000.00
ACU.AX balance_sheet (annual, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 2020000.00
ACU.AX balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 2020000.00
ACU.AX income_statement (annual, 2025-06-30) — Total Other Finance Cost: 144000.00
ACU.AX balance_sheet (annual, 2025-06-30) — Working Capital: 1762000.00
ACU.AX balance_sheet (quarterly, 2025-06-30) — Working Capital: 1762000.00
ACU.V income_statement (annual, 2022-03-31) — +Operating Expense: 4201648.00
ACU.V income_statement (annual, 2022-03-31) — +Total Revenue: 0.00
ACU.V balance_sheet (annual, 2022-03-31) — Accounts Receivable: 103815.00
ACU.V balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -92543.00
ACU.V balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 2718636.00
ACU.V cash_flow (annual, 2022-03-31) — Asset Impairment Charge: -90786.00
ACU.V income_statement (annual, 2022-03-31) — Basic Average Shares: 142725547.00
ACU.V income_statement (annual, 2022-03-31) — Basic EPS: -0.03
ACU.V cash_flow (annual, 2022-03-31) — Beginning Cash Position: 2771624.00
ACU.V balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 242528.00
ACU.V cash_flow (annual, 2022-03-31) — Capital Expenditure: -169540.00
ACU.V balance_sheet (annual, 2022-03-31) — Capital Lease Obligations: 257867.00
ACU.V balance_sheet (annual, 2022-03-31) — Capital Stock: 20472339.00
ACU.V balance_sheet (annual, 2022-03-31) — Cash And Cash Equivalents: 2016667.00
ACU.V balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Short Term Investments: 2016667.00
ACU.V balance_sheet (annual, 2022-03-31) — Cash Financial: 2016667.00
ACU.V cash_flow (annual, 2022-03-31) — Cash Flow From Continuing Financing Activities: 3284147.00
ACU.V cash_flow (annual, 2022-03-31) — Cash Flow From Continuing Investing Activities: -190966.00
ACU.V cash_flow (annual, 2022-03-31) — Cash Flow From Continuing Operating Activities: -3848138.00
ACU.V cash_flow (annual, 2022-03-31) — Change In Account Payable: -102684.00
ACU.V cash_flow (annual, 2022-03-31) — Change In Income Tax Payable: 0.00
ACU.V cash_flow (annual, 2022-03-31) — Change In Inventory: 10055.00
ACU.V cash_flow (annual, 2022-03-31) — Change In Other Working Capital: -4122.00
ACU.V cash_flow (annual, 2022-03-31) — Change In Payable: -102684.00
ACU.V cash_flow (annual, 2022-03-31) — Change In Payables And Accrued Expense: -102684.00
ACU.V cash_flow (annual, 2022-03-31) — Change In Prepaid Assets: 23124.00
ACU.V cash_flow (annual, 2022-03-31) — Change In Receivables: 26185.00
ACU.V cash_flow (annual, 2022-03-31) — Change In Tax Payable: 0.00
ACU.V cash_flow (annual, 2022-03-31) — Change In Working Capital: -47442.00
ACU.V cash_flow (annual, 2022-03-31) — Changes In Cash: -754957.00
ACU.V balance_sheet (annual, 2022-03-31) — Common Stock: 20472339.00
ACU.V balance_sheet (annual, 2022-03-31) — Common Stock Equity: 2475630.00
ACU.V cash_flow (annual, 2022-03-31) — Common Stock Issuance: 3550000.00
ACU.V income_statement (annual, 2022-03-31) — Cost Of Revenue: 0.00
ACU.V balance_sheet (annual, 2022-03-31) — Current Assets: 2493893.00
ACU.V balance_sheet (annual, 2022-03-31) — Current Capital Lease Obligation: 81223.00
ACU.V balance_sheet (annual, 2022-03-31) — Current Debt And Capital Lease Obligation: 81223.00
ACU.V balance_sheet (annual, 2022-03-31) — Current Deferred Liabilities: 0.00
ACU.V balance_sheet (annual, 2022-03-31) — Current Deferred Revenue: 0.00
ACU.V balance_sheet (annual, 2022-03-31) — Current Liabilities: 476500.00
ACU.V cash_flow (annual, 2022-03-31) — Deferred Income Tax: 0.00
ACU.V cash_flow (annual, 2022-03-31) — Deferred Tax: 0.00
ACU.V cash_flow (annual, 2022-03-31) — Depreciation: 148172.00
ACU.V cash_flow (annual, 2022-03-31) — Depreciation Amortization Depletion: 148172.00
ACU.V income_statement (annual, 2022-03-31) — Depreciation Amortization Depletion Income Statement: 148172.00
ACU.V cash_flow (annual, 2022-03-31) — Depreciation And Amortization: 148172.00
ACU.V income_statement (annual, 2022-03-31) — Depreciation And Amortization In Income Statement: 148172.00
ACU.V income_statement (annual, 2022-03-31) — Depreciation Income Statement: 148172.00
ACU.V income_statement (annual, 2022-03-31) — Diluted Average Shares: 142725547.00
ACU.V income_statement (annual, 2022-03-31) — Diluted EPS: -0.03
ACU.V income_statement (annual, 2022-03-31) — Diluted NI Availto Com Stockholders: -4246550.00
ACU.V income_statement (annual, 2022-03-31) — EBIT: -4235470.00
ACU.V income_statement (annual, 2022-03-31) — EBITDA: -4087298.00
ACU.V cash_flow (annual, 2022-03-31) — Effect Of Exchange Rate Changes: 0.00
ACU.V cash_flow (annual, 2022-03-31) — End Cash Position: 2016667.00
ACU.V cash_flow (annual, 2022-03-31) — Financing Cash Flow: 3284147.00
ACU.V balance_sheet (annual, 2022-03-31) — Finished Goods: 0.00
ACU.V cash_flow (annual, 2022-03-31) — Free Cash Flow: -4017678.00
ACU.V cash_flow (annual, 2022-03-31) — Gain Loss On Sale Of PPE: 0.00
ACU.V income_statement (annual, 2022-03-31) — Gain On Sale Of Security: 51964.00
ACU.V balance_sheet (annual, 2022-03-31) — Gains Losses Not Affecting Retained Earnings: 0.00
ACU.V income_statement (annual, 2022-03-31) — General And Administrative Expense: 2422340.00
ACU.V balance_sheet (annual, 2022-03-31) — Goodwill: 0.00
ACU.V balance_sheet (annual, 2022-03-31) — Goodwill And Other Intangible Assets: 202121.00
ACU.V balance_sheet (annual, 2022-03-31) — Gross PPE: 527169.00
ACU.V income_statement (annual, 2022-03-31) — Gross Profit: 0.00
ACU.V income_statement (annual, 2022-03-31) — Interest Expense: 11080.00
ACU.V income_statement (annual, 2022-03-31) — Interest Expense Non Operating: 11080.00
ACU.V cash_flow (annual, 2022-03-31) — Interest Paid Supplemental Data: 18241.00
ACU.V balance_sheet (annual, 2022-03-31) — Inventory: 323661.00
ACU.V balance_sheet (annual, 2022-03-31) — Invested Capital: 2535630.00
ACU.V cash_flow (annual, 2022-03-31) — Investing Cash Flow: -190966.00
ACU.V cash_flow (annual, 2022-03-31) — Issuance Of Capital Stock: 3550000.00
ACU.V cash_flow (annual, 2022-03-31) — Issuance Of Debt: 0.00
ACU.V balance_sheet (annual, 2022-03-31) — Leases: 0.00
ACU.V balance_sheet (annual, 2022-03-31) — Long Term Capital Lease Obligation: 176644.00
ACU.V balance_sheet (annual, 2022-03-31) — Long Term Debt: 60000.00
ACU.V balance_sheet (annual, 2022-03-31) — Long Term Debt And Capital Lease Obligation: 236644.00
ACU.V cash_flow (annual, 2022-03-31) — Long Term Debt Issuance: 0.00
ACU.V cash_flow (annual, 2022-03-31) — Long Term Debt Payments: -92486.00
ACU.V balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 36636.00
ACU.V cash_flow (annual, 2022-03-31) — Net Business Purchase And Sale: 0.00
ACU.V cash_flow (annual, 2022-03-31) — Net Common Stock Issuance: 3550000.00
ACU.V income_statement (annual, 2022-03-31) — Net Income: -4246550.00
ACU.V income_statement (annual, 2022-03-31) — Net Income Common Stockholders: -4246550.00
ACU.V income_statement (annual, 2022-03-31) — Net Income Continuous Operations: -4246550.00
ACU.V income_statement (annual, 2022-03-31) — Net Income From Continuing And Discontinued Operation: -4246550.00
ACU.V income_statement (annual, 2022-03-31) — Net Income From Continuing Operation Net Minority Interest: -4246550.00
ACU.V cash_flow (annual, 2022-03-31) — Net Income From Continuing Operations: -4246550.00
ACU.V income_statement (annual, 2022-03-31) — Net Income Including Noncontrolling Interests: -4246550.00
ACU.V cash_flow (annual, 2022-03-31) — Net Intangibles Purchase And Sale: 0.00
ACU.V income_statement (annual, 2022-03-31) — Net Interest Income: -11080.00
ACU.V cash_flow (annual, 2022-03-31) — Net Issuance Payments Of Debt: -92486.00
ACU.V cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: -92486.00
ACU.V income_statement (annual, 2022-03-31) — Net Non Operating Interest Income Expense: -11080.00
ACU.V cash_flow (annual, 2022-03-31) — Net Other Financing Charges: -288117.00
ACU.V cash_flow (annual, 2022-03-31) — Net Other Investing Changes: -21426.00
ACU.V balance_sheet (annual, 2022-03-31) — Net PPE: 434626.00
ACU.V cash_flow (annual, 2022-03-31) — Net PPE Purchase And Sale: -169540.00
ACU.V balance_sheet (annual, 2022-03-31) — Net Tangible Assets: 2273509.00
ACU.V balance_sheet (annual, 2022-03-31) — Non Current Deferred Liabilities: 0.00
ACU.V balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Liabilities: 0.00
ACU.V income_statement (annual, 2022-03-31) — Normalized EBITDA: -3962690.00
ACU.V income_statement (annual, 2022-03-31) — Normalized Income: -4121942.00
ACU.V cash_flow (annual, 2022-03-31) — Operating Cash Flow: -3848138.00
ACU.V income_statement (annual, 2022-03-31) — Operating Income: -4201648.00
ACU.V income_statement (annual, 2022-03-31) — Operating Revenue: 0.00
ACU.V balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 144974725.00
ACU.V balance_sheet (annual, 2022-03-31) — Other Current Assets: 1815000.00
ACU.V income_statement (annual, 2022-03-31) — Other Gand A: 1098804.00
ACU.V income_statement (annual, 2022-03-31) — Other Income Expense: -33822.00
ACU.V balance_sheet (annual, 2022-03-31) — Other Intangible Assets: 202121.00
ACU.V cash_flow (annual, 2022-03-31) — Other Non Cash Items: 18241.00
ACU.V balance_sheet (annual, 2022-03-31) — Other Non Current Assets: 58134.00
ACU.V income_statement (annual, 2022-03-31) — Other Non Operating Income Expenses: 90786.00
ACU.V income_statement (annual, 2022-03-31) — Other Operating Expenses: -322374.00
ACU.V balance_sheet (annual, 2022-03-31) — Other Properties: 248005.00
ACU.V balance_sheet (annual, 2022-03-31) — Payables And Accrued Expenses: 395277.00
ACU.V balance_sheet (annual, 2022-03-31) — Prepaid Assets: 35781.00
ACU.V income_statement (annual, 2022-03-31) — Pretax Income: -4246550.00
ACU.V cash_flow (annual, 2022-03-31) — Proceeds From Stock Option Exercised: 114750.00
ACU.V balance_sheet (annual, 2022-03-31) — Properties: 0.00
ACU.V income_statement (annual, 2022-03-31) — Provision For Doubtful Accounts: -124209.00
ACU.V cash_flow (annual, 2022-03-31) — Provisionand Write Offof Assets: -124209.00
ACU.V cash_flow (annual, 2022-03-31) — Purchase Of Business: 0.00
ACU.V cash_flow (annual, 2022-03-31) — Purchase Of Intangibles: 0.00
ACU.V cash_flow (annual, 2022-03-31) — Purchase Of PPE: -169540.00
ACU.V balance_sheet (annual, 2022-03-31) — Raw Materials: 323661.00
ACU.V balance_sheet (annual, 2022-03-31) — Receivables: 117784.00
ACU.V income_statement (annual, 2022-03-31) — Reconciled Cost Of Revenue: 0.00
ACU.V income_statement (annual, 2022-03-31) — Reconciled Depreciation: 148172.00
ACU.V cash_flow (annual, 2022-03-31) — Repayment Of Debt: -92486.00
ACU.V income_statement (annual, 2022-03-31) — Research And Development: 1974663.00
ACU.V income_statement (annual, 2022-03-31) — Restructuring And Mergern Acquisition: 176572.00
ACU.V balance_sheet (annual, 2022-03-31) — Retained Earnings: -20715345.00
ACU.V income_statement (annual, 2022-03-31) — Salaries And Wages: 1323536.00
ACU.V cash_flow (annual, 2022-03-31) — Sale Of Business: 0.00
ACU.V income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 103056.00
ACU.V income_statement (annual, 2022-03-31) — Selling General And Administration: 2525396.00
ACU.V balance_sheet (annual, 2022-03-31) — Share Issued: 144974725.00
ACU.V income_statement (annual, 2022-03-31) — Special Income Charges: -176572.00
ACU.V cash_flow (annual, 2022-03-31) — Stock Based Compensation: 494436.00
ACU.V balance_sheet (annual, 2022-03-31) — Stockholders Equity: 2475630.00
ACU.V balance_sheet (annual, 2022-03-31) — Tangible Book Value: 2273509.00
ACU.V income_statement (annual, 2022-03-31) — Tax Effect Of Unusual Items: 0.00
ACU.V income_statement (annual, 2022-03-31) — Tax Rate For Calcs: 0.00
ACU.V balance_sheet (annual, 2022-03-31) — Taxes Receivable: 13969.00
ACU.V balance_sheet (annual, 2022-03-31) — Total Assets: 3188774.00
ACU.V balance_sheet (annual, 2022-03-31) — Total Capitalization: 2535630.00
ACU.V balance_sheet (annual, 2022-03-31) — Total Debt: 317867.00
ACU.V balance_sheet (annual, 2022-03-31) — Total Equity Gross Minority Interest: 2475630.00
ACU.V income_statement (annual, 2022-03-31) — Total Expenses: 4201648.00
ACU.V balance_sheet (annual, 2022-03-31) — Total Liabilities Net Minority Interest: 713144.00
ACU.V balance_sheet (annual, 2022-03-31) — Total Non Current Assets: 694881.00
ACU.V balance_sheet (annual, 2022-03-31) — Total Non Current Liabilities Net Minority Interest: 236644.00
ACU.V income_statement (annual, 2022-03-31) — Total Operating Income As Reported: -4381272.00
ACU.V income_statement (annual, 2022-03-31) — Total Unusual Items: -124608.00
ACU.V income_statement (annual, 2022-03-31) — Total Unusual Items Excluding Goodwill: -124608.00
ACU.V balance_sheet (annual, 2022-03-31) — Work In Process: 0.00
ACU.V balance_sheet (annual, 2022-03-31) — Working Capital: 2017393.00
ACU.V income_statement (annual, 2022-03-31) — Write Off: 0.00
ACU.V income_statement (annual, 2023-03-31) — +Operating Expense: 6243874.00
ACU.V income_statement (annual, 2023-03-31) — +Total Revenue: 5508737.00
ACU.V balance_sheet (annual, 2023-03-31) — Accounts Receivable: 1183456.00
ACU.V balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -325082.00
ACU.V balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 2932168.00
ACU.V cash_flow (annual, 2023-03-31) — Asset Impairment Charge: 818158.00
ACU.V income_statement (annual, 2023-03-31) — Basic Average Shares: 191319761.00
ACU.V income_statement (annual, 2023-03-31) — Basic EPS: -0.02
ACU.V cash_flow (annual, 2023-03-31) — Beginning Cash Position: 2016667.00
ACU.V balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 293377.00
ACU.V cash_flow (annual, 2023-03-31) — Capital Expenditure: -89714.00
ACU.V balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 253303.00
ACU.V balance_sheet (annual, 2023-03-31) — Capital Stock: 27706728.00
ACU.V balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 2801217.00
ACU.V balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 2801217.00
ACU.V balance_sheet (annual, 2023-03-31) — Cash Financial: 2801217.00
ACU.V cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Financing Activities: 910470.00
ACU.V cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Investing Activities: 2238239.00
ACU.V cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Operating Activities: -2426670.00
ACU.V cash_flow (annual, 2023-03-31) — Change In Account Payable: -57611.00
ACU.V cash_flow (annual, 2023-03-31) — Change In Income Tax Payable: -36182.00
ACU.V cash_flow (annual, 2023-03-31) — Change In Inventory: 289536.00
ACU.V cash_flow (annual, 2023-03-31) — Change In Other Working Capital: -534081.00
ACU.V cash_flow (annual, 2023-03-31) — Change In Payable: -93793.00
ACU.V cash_flow (annual, 2023-03-31) — Change In Payables And Accrued Expense: -93793.00
ACU.V cash_flow (annual, 2023-03-31) — Change In Prepaid Assets: 58765.00
ACU.V cash_flow (annual, 2023-03-31) — Change In Receivables: 31097.00
ACU.V cash_flow (annual, 2023-03-31) — Change In Tax Payable: -36182.00
ACU.V cash_flow (annual, 2023-03-31) — Change In Working Capital: -248476.00
ACU.V cash_flow (annual, 2023-03-31) — Changes In Cash: 722039.00
ACU.V balance_sheet (annual, 2023-03-31) — Common Stock: 27706728.00
ACU.V balance_sheet (annual, 2023-03-31) — Common Stock Equity: 5603343.00
ACU.V cash_flow (annual, 2023-03-31) — Common Stock Issuance: 1165000.00
ACU.V income_statement (annual, 2023-03-31) — Cost Of Revenue: 2753972.00
ACU.V balance_sheet (annual, 2023-03-31) — Current Assets: 7379304.00
ACU.V balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 157564.00
ACU.V balance_sheet (annual, 2023-03-31) — Current Debt: 60000.00
ACU.V balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 217564.00
ACU.V balance_sheet (annual, 2023-03-31) — Current Deferred Liabilities: 1908242.00
ACU.V balance_sheet (annual, 2023-03-31) — Current Deferred Revenue: 1908242.00
ACU.V balance_sheet (annual, 2023-03-31) — Current Liabilities: 3647443.00
ACU.V balance_sheet (annual, 2023-03-31) — Current Provisions: 330251.00
ACU.V cash_flow (annual, 2023-03-31) — Deferred Income Tax: 156702.00
ACU.V cash_flow (annual, 2023-03-31) — Deferred Tax: 156702.00
ACU.V cash_flow (annual, 2023-03-31) — Depreciation: 495907.00
ACU.V cash_flow (annual, 2023-03-31) — Depreciation Amortization Depletion: 495907.00
ACU.V income_statement (annual, 2023-03-31) — Depreciation Amortization Depletion Income Statement: 495907.00
ACU.V cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 495907.00
ACU.V income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 495907.00
ACU.V income_statement (annual, 2023-03-31) — Depreciation Income Statement: 495907.00
ACU.V income_statement (annual, 2023-03-31) — Diluted Average Shares: 191319761.00
ACU.V income_statement (annual, 2023-03-31) — Diluted EPS: -0.02
ACU.V income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: -4479803.00
ACU.V income_statement (annual, 2023-03-31) — EBIT: -4653657.00
ACU.V income_statement (annual, 2023-03-31) — EBITDA: -4157750.00
ACU.V cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: 62511.00
ACU.V cash_flow (annual, 2023-03-31) — End Cash Position: 2801217.00
ACU.V cash_flow (annual, 2023-03-31) — Financing Cash Flow: 910470.00
ACU.V balance_sheet (annual, 2023-03-31) — Finished Goods: 483043.00
ACU.V cash_flow (annual, 2023-03-31) — Free Cash Flow: -2516384.00
ACU.V cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: 11310.00
ACU.V income_statement (annual, 2023-03-31) — Gain On Sale Of Security: 38485.00
ACU.V balance_sheet (annual, 2023-03-31) — Gains Losses Not Affecting Retained Earnings: 159595.00
ACU.V income_statement (annual, 2023-03-31) — General And Administrative Expense: 3398596.00
ACU.V balance_sheet (annual, 2023-03-31) — Goodwill: 628927.00
ACU.V balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 1515197.00
ACU.V balance_sheet (annual, 2023-03-31) — Gross PPE: 800823.00
ACU.V income_statement (annual, 2023-03-31) — Gross Profit: 2754765.00
ACU.V income_statement (annual, 2023-03-31) — Impairment Of Capital Assets: 8437.00
ACU.V income_statement (annual, 2023-03-31) — Interest Expense: 19030.00
ACU.V income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 19030.00
ACU.V cash_flow (annual, 2023-03-31) — Interest Paid Supplemental Data: 19030.00
ACU.V balance_sheet (annual, 2023-03-31) — Inventory: 3233077.00
ACU.V balance_sheet (annual, 2023-03-31) — Invested Capital: 5663343.00
ACU.V cash_flow (annual, 2023-03-31) — Investing Cash Flow: 2238239.00
ACU.V cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 1165000.00
ACU.V balance_sheet (annual, 2023-03-31) — Leases: 21604.00
ACU.V balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 95739.00
ACU.V balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 95739.00
ACU.V cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -198830.00
ACU.V balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 63074.00
ACU.V cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: 2348179.00
ACU.V cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 1165000.00
ACU.V income_statement (annual, 2023-03-31) — Net Income: -4479803.00
ACU.V income_statement (annual, 2023-03-31) — Net Income Common Stockholders: -4479803.00
ACU.V income_statement (annual, 2023-03-31) — Net Income Continuous Operations: -4479803.00
ACU.V income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: -4479803.00
ACU.V income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: -4479803.00
ACU.V cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: -4479803.00
ACU.V income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: -4479803.00
ACU.V cash_flow (annual, 2023-03-31) — Net Intangibles Purchase And Sale: -28387.00
ACU.V income_statement (annual, 2023-03-31) — Net Interest Income: -19030.00
ACU.V cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: -198830.00
ACU.V cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: -198830.00
ACU.V income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -19030.00
ACU.V cash_flow (annual, 2023-03-31) — Net Other Financing Charges: -61700.00
ACU.V cash_flow (annual, 2023-03-31) — Net Other Investing Changes: -20226.00
ACU.V balance_sheet (annual, 2023-03-31) — Net PPE: 475741.00
ACU.V cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -61327.00
ACU.V balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 4088146.00
ACU.V balance_sheet (annual, 2023-03-31) — Non Current Deferred Liabilities: 75779.00
ACU.V balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 75779.00
ACU.V income_statement (annual, 2023-03-31) — Normalized EBITDA: -2984842.00
ACU.V income_statement (annual, 2023-03-31) — Normalized Income: -3355311.51
ACU.V cash_flow (annual, 2023-03-31) — Operating Cash Flow: -2426670.00
ACU.V cash_flow (annual, 2023-03-31) — Operating Gains Losses: 11310.00
ACU.V income_statement (annual, 2023-03-31) — Operating Income: -3489109.00
ACU.V income_statement (annual, 2023-03-31) — Operating Revenue: 5508737.00
ACU.V balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 222194076.00
ACU.V balance_sheet (annual, 2023-03-31) — Other Current Borrowings: 60000.00
ACU.V balance_sheet (annual, 2023-03-31) — Other Equity Adjustments: 159595.00
ACU.V income_statement (annual, 2023-03-31) — Other Gand A: 1298484.00
ACU.V income_statement (annual, 2023-03-31) — Other Income Expense: -1164547.00
ACU.V balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 886270.00
ACU.V cash_flow (annual, 2023-03-31) — Other Non Cash Items: 275684.00
ACU.V balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 52062.00
ACU.V income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 8361.00
ACU.V balance_sheet (annual, 2023-03-31) — Other Properties: 422768.00
ACU.V balance_sheet (annual, 2023-03-31) — Payables And Accrued Expenses: 1191386.00
ACU.V balance_sheet (annual, 2023-03-31) — Prepaid Assets: 91429.00
ACU.V income_statement (annual, 2023-03-31) — Pretax Income: -4672687.00
ACU.V cash_flow (annual, 2023-03-31) — Proceeds From Stock Option Exercised: 6000.00
ACU.V balance_sheet (annual, 2023-03-31) — Properties: 0.00
ACU.V income_statement (annual, 2023-03-31) — Provision For Doubtful Accounts: 0.00
ACU.V cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 0.00
ACU.V cash_flow (annual, 2023-03-31) — Purchase Of Business: -1205310.00
ACU.V cash_flow (annual, 2023-03-31) — Purchase Of Intangibles: -28387.00
ACU.V cash_flow (annual, 2023-03-31) — Purchase Of PPE: -61327.00
ACU.V balance_sheet (annual, 2023-03-31) — Raw Materials: 1942935.00
ACU.V balance_sheet (annual, 2023-03-31) — Receivables: 1253581.00
ACU.V income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 2753972.00
ACU.V income_statement (annual, 2023-03-31) — Reconciled Depreciation: 495907.00
ACU.V cash_flow (annual, 2023-03-31) — Repayment Of Debt: -198830.00
ACU.V income_statement (annual, 2023-03-31) — Research And Development: 1411220.00
ACU.V income_statement (annual, 2023-03-31) — Restructuring And Mergern Acquisition: 894008.00
ACU.V balance_sheet (annual, 2023-03-31) — Retained Earnings: -25195148.00
ACU.V income_statement (annual, 2023-03-31) — Salaries And Wages: 2100112.00
ACU.V cash_flow (annual, 2023-03-31) — Sale Of Business: 3553489.00
ACU.V cash_flow (annual, 2023-03-31) — Sale Of PPE: 0.00
ACU.V income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 938151.00
ACU.V income_statement (annual, 2023-03-31) — Selling General And Administration: 4336747.00
ACU.V balance_sheet (annual, 2023-03-31) — Share Issued: 222194076.00
ACU.V income_statement (annual, 2023-03-31) — Special Income Charges: -1211393.00
ACU.V cash_flow (annual, 2023-03-31) — Stock Based Compensation: 543848.00
ACU.V balance_sheet (annual, 2023-03-31) — Stockholders Equity: 5603343.00
ACU.V balance_sheet (annual, 2023-03-31) — Tangible Book Value: 4088146.00
ACU.V income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: -48416.51
ACU.V income_statement (annual, 2023-03-31) — Tax Provision: -192884.00
ACU.V income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.04
ACU.V balance_sheet (annual, 2023-03-31) — Taxes Receivable: 70125.00
ACU.V balance_sheet (annual, 2023-03-31) — Total Assets: 9422304.00
ACU.V balance_sheet (annual, 2023-03-31) — Total Capitalization: 5603343.00
ACU.V balance_sheet (annual, 2023-03-31) — Total Debt: 313303.00
ACU.V balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 5603343.00
ACU.V income_statement (annual, 2023-03-31) — Total Expenses: 8997846.00
ACU.V balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 3818961.00
ACU.V balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 2043000.00
ACU.V balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 171518.00
ACU.V income_statement (annual, 2023-03-31) — Total Operating Income As Reported: -3768010.00
ACU.V income_statement (annual, 2023-03-31) — Total Unusual Items: -1172908.00
ACU.V income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: -1172908.00
ACU.V balance_sheet (annual, 2023-03-31) — Work In Process: 807099.00
ACU.V balance_sheet (annual, 2023-03-31) — Working Capital: 3731861.00
ACU.V income_statement (annual, 2023-03-31) — Write Off: 308948.00
ACU.V income_statement (annual, 2024-03-31) — +Operating Expense: 6660353.00
ACU.V income_statement (annual, 2024-03-31) — +Total Revenue: 10914622.00
ACU.V balance_sheet (annual, 2024-03-31) — Accounts Receivable: 604974.00
ACU.V balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -449961.00
ACU.V balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 3205293.00
ACU.V cash_flow (annual, 2024-03-31) — Asset Impairment Charge: 191038.00
ACU.V income_statement (annual, 2024-03-31) — Basic Average Shares: 222194076.00
ACU.V income_statement (annual, 2024-03-31) — Basic EPS: 0.00
ACU.V cash_flow (annual, 2024-03-31) — Beginning Cash Position: 2801217.00
ACU.V balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 463495.00
ACU.V cash_flow (annual, 2024-03-31) — Capital Expenditure: -373906.00
ACU.V balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 307956.00
ACU.V balance_sheet (annual, 2024-03-31) — Capital Stock: 27706728.00
ACU.V balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 2850338.00
ACU.V balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 2850338.00
ACU.V cash_flow (annual, 2024-03-31) — Cash Dividends Paid: 0.00
ACU.V balance_sheet (annual, 2024-03-31) — Cash Financial: 2850338.00
ACU.V cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Financing Activities: -236033.00
ACU.V cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Investing Activities: -262903.00
ACU.V cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Operating Activities: 409474.00
ACU.V cash_flow (annual, 2024-03-31) — Change In Account Payable: 60061.00
ACU.V cash_flow (annual, 2024-03-31) — Change In Income Tax Payable: 19936.00
ACU.V cash_flow (annual, 2024-03-31) — Change In Inventory: -574317.00
ACU.V cash_flow (annual, 2024-03-31) — Change In Other Working Capital: 520858.00
ACU.V cash_flow (annual, 2024-03-31) — Change In Payable: 79997.00
ACU.V cash_flow (annual, 2024-03-31) — Change In Payables And Accrued Expense: 79997.00
ACU.V cash_flow (annual, 2024-03-31) — Change In Prepaid Assets: -527431.00
ACU.V cash_flow (annual, 2024-03-31) — Change In Receivables: 398331.00
ACU.V cash_flow (annual, 2024-03-31) — Change In Tax Payable: 19936.00
ACU.V cash_flow (annual, 2024-03-31) — Change In Working Capital: -102562.00
ACU.V cash_flow (annual, 2024-03-31) — Changes In Cash: -89462.00
ACU.V balance_sheet (annual, 2024-03-31) — Common Stock: 27706728.00
ACU.V balance_sheet (annual, 2024-03-31) — Common Stock Equity: 5816426.00
ACU.V cash_flow (annual, 2024-03-31) — Common Stock Issuance: 0.00
ACU.V income_statement (annual, 2024-03-31) — Cost Of Revenue: 4701702.00
ACU.V balance_sheet (annual, 2024-03-31) — Current Assets: 8024872.00
ACU.V balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 199262.00
ACU.V balance_sheet (annual, 2024-03-31) — Current Debt: 6801.00
ACU.V balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 206063.00
ACU.V balance_sheet (annual, 2024-03-31) — Current Deferred Liabilities: 2318057.00
ACU.V balance_sheet (annual, 2024-03-31) — Current Deferred Revenue: 2318057.00
ACU.V balance_sheet (annual, 2024-03-31) — Current Liabilities: 4198615.00
ACU.V balance_sheet (annual, 2024-03-31) — Current Provisions: 401970.00
ACU.V cash_flow (annual, 2024-03-31) — Deferred Income Tax: -237219.00
ACU.V cash_flow (annual, 2024-03-31) — Deferred Tax: -237219.00
ACU.V cash_flow (annual, 2024-03-31) — Depreciation: 519448.00
ACU.V cash_flow (annual, 2024-03-31) — Depreciation Amortization Depletion: 519448.00
ACU.V income_statement (annual, 2024-03-31) — Depreciation Amortization Depletion Income Statement: 519448.00
ACU.V cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 519448.00
ACU.V income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 519448.00
ACU.V income_statement (annual, 2024-03-31) — Depreciation Income Statement: 519448.00
ACU.V income_statement (annual, 2024-03-31) — Diluted Average Shares: 222194076.00
ACU.V income_statement (annual, 2024-03-31) — Diluted EPS: 0.00
ACU.V income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: -217637.00
ACU.V income_statement (annual, 2024-03-31) — EBIT: -340362.00
ACU.V income_statement (annual, 2024-03-31) — EBITDA: 179086.00
ACU.V cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: 138583.00
ACU.V cash_flow (annual, 2024-03-31) — End Cash Position: 2850338.00
ACU.V cash_flow (annual, 2024-03-31) — Financing Cash Flow: -236033.00
ACU.V balance_sheet (annual, 2024-03-31) — Finished Goods: 91982.00
ACU.V cash_flow (annual, 2024-03-31) — Free Cash Flow: 35568.00
ACU.V cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: 344.00
ACU.V income_statement (annual, 2024-03-31) — Gain On Sale Of Security: 131871.00
ACU.V balance_sheet (annual, 2024-03-31) — Gains Losses Not Affecting Retained Earnings: 317190.00
ACU.V income_statement (annual, 2024-03-31) — General And Administrative Expense: 4039549.00
ACU.V balance_sheet (annual, 2024-03-31) — Goodwill: 628927.00
ACU.V balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 1369410.00
ACU.V balance_sheet (annual, 2024-03-31) — Gross PPE: 1094517.00
ACU.V income_statement (annual, 2024-03-31) — Gross Profit: 6212920.00
ACU.V income_statement (annual, 2024-03-31) — Impairment Of Capital Assets: 18382.00
ACU.V income_statement (annual, 2024-03-31) — Interest Expense: 19907.00
ACU.V income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 19907.00
ACU.V cash_flow (annual, 2024-03-31) — Interest Paid Cff: -19907.00
ACU.V cash_flow (annual, 2024-03-31) — Interest Paid Supplemental Data: 19907.00
ACU.V balance_sheet (annual, 2024-03-31) — Inventory: 3634738.00
ACU.V balance_sheet (annual, 2024-03-31) — Invested Capital: 5855347.00
ACU.V cash_flow (annual, 2024-03-31) — Investing Cash Flow: -262903.00
ACU.V cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 0.00
ACU.V cash_flow (annual, 2024-03-31) — Issuance Of Debt: 0.00
ACU.V balance_sheet (annual, 2024-03-31) — Leases: 21129.00
ACU.V balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 108694.00
ACU.V balance_sheet (annual, 2024-03-31) — Long Term Debt: 32120.00
ACU.V balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 140814.00
ACU.V cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 0.00
ACU.V cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -216126.00
ACU.V balance_sheet (annual, 2024-03-31) — Long Term Provisions: 39324.00
ACU.V balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 97909.00
ACU.V cash_flow (annual, 2024-03-31) — Net Business Purchase And Sale: 0.00
ACU.V cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 0.00
ACU.V income_statement (annual, 2024-03-31) — Net Income: -217637.00
ACU.V income_statement (annual, 2024-03-31) — Net Income Common Stockholders: -217637.00
ACU.V income_statement (annual, 2024-03-31) — Net Income Continuous Operations: -217637.00
ACU.V income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: -217637.00
ACU.V income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: -217637.00
ACU.V cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: -217637.00
ACU.V income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: -217637.00
ACU.V cash_flow (annual, 2024-03-31) — Net Intangibles Purchase And Sale: -36341.00
ACU.V income_statement (annual, 2024-03-31) — Net Interest Income: -19907.00
ACU.V cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: -216126.00
ACU.V cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: -216126.00
ACU.V income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: -19907.00
ACU.V cash_flow (annual, 2024-03-31) — Net Other Investing Changes: -8523.00
ACU.V balance_sheet (annual, 2024-03-31) — Net PPE: 644556.00
ACU.V cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -218039.00
ACU.V balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 4447016.00
ACU.V balance_sheet (annual, 2024-03-31) — Non Current Deferred Assets: 95754.00
ACU.V balance_sheet (annual, 2024-03-31) — Non Current Deferred Liabilities: 0.00
ACU.V balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 95754.00
ACU.V balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 0.00
ACU.V income_statement (annual, 2024-03-31) — Normalized EBITDA: 45597.00
ACU.V income_statement (annual, 2024-03-31) — Normalized Income: -298277.15
ACU.V cash_flow (annual, 2024-03-31) — Operating Cash Flow: 409474.00
ACU.V cash_flow (annual, 2024-03-31) — Operating Gains Losses: 344.00
ACU.V income_statement (annual, 2024-03-31) — Operating Income: -447433.00
ACU.V income_statement (annual, 2024-03-31) — Operating Revenue: 10914622.00
ACU.V balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 222194076.00
ACU.V balance_sheet (annual, 2024-03-31) — Other Current Borrowings: 6801.00
ACU.V balance_sheet (annual, 2024-03-31) — Other Equity Adjustments: 317190.00
ACU.V income_statement (annual, 2024-03-31) — Other Gand A: 1268983.00
ACU.V income_statement (annual, 2024-03-31) — Other Income Expense: 107070.00
ACU.V balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 740483.00
ACU.V cash_flow (annual, 2024-03-31) — Other Non Cash Items: -17063.00
ACU.V balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 60587.00
ACU.V income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: -26419.00
ACU.V income_statement (annual, 2024-03-31) — Other Operating Expenses: 233844.00
ACU.V balance_sheet (annual, 2024-03-31) — Other Properties: 511984.00
ACU.V income_statement (annual, 2024-03-31) — Other Special Charges: -20000.00
ACU.V balance_sheet (annual, 2024-03-31) — Payables And Accrued Expenses: 1272525.00
ACU.V balance_sheet (annual, 2024-03-31) — Prepaid Assets: 618860.00
ACU.V income_statement (annual, 2024-03-31) — Pretax Income: -360269.00
ACU.V cash_flow (annual, 2024-03-31) — Proceeds From Stock Option Exercised: 0.00
ACU.V balance_sheet (annual, 2024-03-31) — Properties: 0.00
ACU.V cash_flow (annual, 2024-03-31) — Purchase Of Business: 0.00
ACU.V cash_flow (annual, 2024-03-31) — Purchase Of Intangibles: -36341.00
ACU.V cash_flow (annual, 2024-03-31) — Purchase Of PPE: -337565.00
ACU.V balance_sheet (annual, 2024-03-31) — Raw Materials: 2553860.00
ACU.V balance_sheet (annual, 2024-03-31) — Receivables: 920936.00
ACU.V income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 4701702.00
ACU.V income_statement (annual, 2024-03-31) — Reconciled Depreciation: 519448.00
ACU.V cash_flow (annual, 2024-03-31) — Repayment Of Debt: -216126.00
ACU.V income_statement (annual, 2024-03-31) — Research And Development: 838911.00
ACU.V balance_sheet (annual, 2024-03-31) — Restricted Cash: 0.00
ACU.V income_statement (annual, 2024-03-31) — Restructuring And Mergern Acquisition: 0.00
ACU.V balance_sheet (annual, 2024-03-31) — Retained Earnings: -25412785.00
ACU.V income_statement (annual, 2024-03-31) — Salaries And Wages: 2770566.00
ACU.V cash_flow (annual, 2024-03-31) — Sale Of Business: 0.00
ACU.V cash_flow (annual, 2024-03-31) — Sale Of PPE: 119526.00
ACU.V income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 1028601.00
ACU.V income_statement (annual, 2024-03-31) — Selling General And Administration: 5068150.00
ACU.V balance_sheet (annual, 2024-03-31) — Share Issued: 222194076.00
ACU.V income_statement (annual, 2024-03-31) — Special Income Charges: 1618.00
ACU.V cash_flow (annual, 2024-03-31) — Stock Based Compensation: 273125.00
ACU.V balance_sheet (annual, 2024-03-31) — Stockholders Equity: 5816426.00
ACU.V balance_sheet (annual, 2024-03-31) — Tangible Book Value: 4447016.00
ACU.V income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 52848.85
ACU.V income_statement (annual, 2024-03-31) — Tax Provision: -142632.00
ACU.V income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.40
ACU.V balance_sheet (annual, 2024-03-31) — Taxes Receivable: 315962.00
ACU.V balance_sheet (annual, 2024-03-31) — Total Assets: 10195179.00
ACU.V balance_sheet (annual, 2024-03-31) — Total Capitalization: 5848546.00
ACU.V balance_sheet (annual, 2024-03-31) — Total Debt: 346877.00
ACU.V balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 5816426.00
ACU.V income_statement (annual, 2024-03-31) — Total Expenses: 11362055.00
ACU.V balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 4378753.00
ACU.V balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 2170307.00
ACU.V balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 180138.00
ACU.V income_statement (annual, 2024-03-31) — Total Operating Income As Reported: 333943.00
ACU.V income_statement (annual, 2024-03-31) — Total Unusual Items: 133489.00
ACU.V income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 133489.00
ACU.V balance_sheet (annual, 2024-03-31) — Treasury Shares Number: 0.00
ACU.V balance_sheet (annual, 2024-03-31) — Work In Process: 988896.00
ACU.V balance_sheet (annual, 2024-03-31) — Working Capital: 3826257.00
ACU.V income_statement (annual, 2024-03-31) — Write Off: 0.00
ACU.V income_statement (quarterly, 2024-09-30) — Basic Average Shares: 222194076.00
ACU.V income_statement (quarterly, 2024-09-30) — Basic EPS: 0.00
ACU.V cash_flow (quarterly, 2024-09-30) — Cash Dividends Paid: 0.00
ACU.V cash_flow (quarterly, 2024-09-30) — Changes In Account Receivables: 538119.00
ACU.V income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 222194076.00
ACU.V income_statement (quarterly, 2024-09-30) — Diluted EPS: 0.00
ACU.V balance_sheet (quarterly, 2024-09-30) — Goodwill: 628927.00
ACU.V income_statement (quarterly, 2024-09-30) — Impairment Of Capital Assets: 0.00
ACU.V cash_flow (quarterly, 2024-09-30) — Interest Paid Cff: 0.00
ACU.V balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 0.00
ACU.V cash_flow (quarterly, 2024-09-30) — Net Other Investing Changes: -8256.00
ACU.V balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Assets: 277310.00
ACU.V balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Assets: 277310.00
ACU.V balance_sheet (quarterly, 2024-09-30) — Other Current Borrowings: 7095.00
ACU.V income_statement (quarterly, 2024-09-30) — Write Off: 0.00
ACU.V income_statement (quarterly, 2024-12-31) — +Operating Expense: 1520637.00
ACU.V income_statement (quarterly, 2024-12-31) — +Total Revenue: 1416501.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Accounts Receivable: 399257.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -715765.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Additional Paid In Capital: 3423373.00
ACU.V cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: 0.00
ACU.V income_statement (quarterly, 2024-12-31) — Basic Average Shares: 222194076.00
ACU.V income_statement (quarterly, 2024-12-31) — Basic EPS: -0.01
ACU.V cash_flow (quarterly, 2024-12-31) — Beginning Cash Position: 1439471.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 508187.00
ACU.V cash_flow (quarterly, 2024-12-31) — Capital Expenditure: -81794.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 187547.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Capital Stock: 27706728.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Cash And Cash Equivalents: 1169977.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 1169977.00
ACU.V cash_flow (quarterly, 2024-12-31) — Cash Dividends Paid: 0.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Cash Financial: 1169977.00
ACU.V cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Financing Activities: -46647.00
ACU.V cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Investing Activities: -81794.00
ACU.V cash_flow (quarterly, 2024-12-31) — Cash Flow From Continuing Operating Activities: -616309.00
ACU.V cash_flow (quarterly, 2024-12-31) — Change In Inventory: 298436.00
ACU.V cash_flow (quarterly, 2024-12-31) — Change In Other Working Capital: 209167.00
ACU.V cash_flow (quarterly, 2024-12-31) — Change In Payables And Accrued Expense: -192184.00
ACU.V cash_flow (quarterly, 2024-12-31) — Change In Prepaid Assets: 185103.00
ACU.V cash_flow (quarterly, 2024-12-31) — Change In Receivables: -187302.00
ACU.V cash_flow (quarterly, 2024-12-31) — Change In Working Capital: 313220.00
ACU.V cash_flow (quarterly, 2024-12-31) — Changes In Account Receivables: -187302.00
ACU.V cash_flow (quarterly, 2024-12-31) — Changes In Cash: -115823.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Common Stock: 27706728.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Common Stock Equity: 4179944.00
ACU.V income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 683360.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Current Assets: 5773945.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 187547.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Current Debt: 7247.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Current Debt And Capital Lease Obligation: 194794.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Current Deferred Liabilities: 1913434.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Current Deferred Revenue: 1913434.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Current Liabilities: 3118117.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Current Provisions: 86891.00
ACU.V cash_flow (quarterly, 2024-12-31) — Deferred Income Tax: -91345.00
ACU.V cash_flow (quarterly, 2024-12-31) — Deferred Tax: -91345.00
ACU.V cash_flow (quarterly, 2024-12-31) — Depreciation: 202218.00
ACU.V cash_flow (quarterly, 2024-12-31) — Depreciation Amortization Depletion: 202218.00
ACU.V income_statement (quarterly, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 202218.00
ACU.V cash_flow (quarterly, 2024-12-31) — Depreciation And Amortization: 202218.00
ACU.V income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 202218.00
ACU.V income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 202218.00
ACU.V income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 222194076.00
ACU.V income_statement (quarterly, 2024-12-31) — Diluted EPS: -0.01
ACU.V income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: -1126315.00
ACU.V income_statement (quarterly, 2024-12-31) — EBIT: -1214639.00
ACU.V income_statement (quarterly, 2024-12-31) — EBITDA: -1012421.00
ACU.V cash_flow (quarterly, 2024-12-31) — Effect Of Exchange Rate Changes: -153671.00
ACU.V cash_flow (quarterly, 2024-12-31) — End Cash Position: 1169977.00
ACU.V cash_flow (quarterly, 2024-12-31) — Financing Cash Flow: -46647.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Finished Goods: 317759.00
ACU.V cash_flow (quarterly, 2024-12-31) — Free Cash Flow: -69176.00
ACU.V cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
ACU.V income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: 201604.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: 451426.00
ACU.V income_statement (quarterly, 2024-12-31) — General And Administrative Expense: 958226.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Goodwill: 0.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Goodwill And Other Intangible Assets: 656766.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Gross PPE: 1298858.00
ACU.V income_statement (quarterly, 2024-12-31) — Gross Profit: 733141.00
ACU.V income_statement (quarterly, 2024-12-31) — Impairment Of Capital Assets: 628927.00
ACU.V income_statement (quarterly, 2024-12-31) — Interest Expense: 3020.00
ACU.V income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 3020.00
ACU.V cash_flow (quarterly, 2024-12-31) — Interest Paid Cff: -8663.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Inventory: 3909395.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Invested Capital: 4213819.00
ACU.V cash_flow (quarterly, 2024-12-31) — Investing Cash Flow: -81794.00
ACU.V cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 0.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Leases: 21442.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 0.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 26628.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 26628.00
ACU.V cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: -37984.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Long Term Provisions: 125568.00
ACU.V balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 111521.00
ACU.V income_statement (quarterly, 2024-12-31) — Net Income: -1126315.00
ACU.V income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: -1126315.00
ACU.V income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: -1126315.00
ACU.V income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -1126315.00
ACU.V income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -1126315.00
ACU.V cash_flow (quarterly, 2024-12-31) — Net Income From Continuing Operations: -1126315.00
ACU.V income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: -1126315.00
ACU.V cash_flow (quarterly, 2024-12-31) — Net Intangibles Purchase And Sale: -27.00
ACU.V income_statement (quarterly, 2024-12-31) — Net Interest Income: -3020.00
ACU.V cash_flow (quarterly, 2024-12-31) — Net Issuance Payments Of Debt: -37984.00
ACU.V cash_flow (quarterly, 2024-12-31) — Net Long Term Debt Issuance: -37984.00